Pine Pharmaceuticals recalls
4 official recalls and safety alerts involving Pine Pharmaceuticals since 2022-09, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.
This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with Pine Pharmaceuticals or the relevant agency.
- 2023-10-25
US- 2023-04-19
- US
Pine Pharmaceuticals, LLC recalls Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in individually labeled…
Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.
- 2023-01-11
- US
Pine Pharmaceuticals, LLC recalls Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular Injection, 1 ml, Single Dose Vial, Compounded by Pine…
CGMP Deviations: Raw material recalled by repackager, due to discoloration.
- 2022-09-21
- US
Pine Pharmaceuticals, LLC recalls Bupivacaine HCl 0.375% w/v and Lidocaine HCl 2% w/v Solution for Retrobulbar or Peribulbar Injection; packaged in a) 10 mL prefilled…
Lack of Assurance of Sterility
FDA · DrugPine Pharmaceuticals, LLCProduct was distributed to direct accounts in AL, CA, NC and NYOfficial notice →